Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies.
NVS Key Statistics
NVS News
HSBC last night upgraded Novartis (NVS) to Hold from Reduce with a price target of $136, up from $123. The firm believes the company’s negative catalyst path ha...
Citi lowered the firm’s price target on Novartis (NVS) to CHF 135 from CHF 142 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate s...
JPMorgan analyst Tessa Romero downgraded Dyne Therapeutics (DYN) to Underweight from Neutral with a price target of $10, down from $17. The firm believes Novart...
Analyst ratings
53%
of 30 ratingsMore NVS News
RBC Capital initiated coverage of Novartis (NVS) with a Sector Perform rating and CHF 120 price target The unexpected pelacarsen failure and del-desiran DM1 set...
Eli Lilly’s (LLY) stock is down 2% on reports that rival Novartis’ (NVS) new cholesterol drug failed a closely watched cardiovascular trial. The failure of the...
After Sarepta (SRPT) competitor Novartis (NVS) reported that its Phase 3 HARBOR trial of del-desiran in myotonic dystrophy type 1 failed to achieve statistical...
Amgen Inc. (NASDAQ:AMGN) cratered 9.8% to $394.56 Tuesday, on track for its worst single-day loss since October 2000. The damage came from a rival. Novartis A...
H.C. Wainwright reiterates a Sell rating on Sarepta (SRPT) with a $5 price target after Novartis (NVS) said its Phase 3 study of del-desiran missed its placebo-...
A major clinical-trial failure last week is rippling across biopharma stocks on Tuesday morning, showing yet again how risky it is to invest in drug development...
The S&P is pointed toward a weaker open as a renewed jump in oil prices and escalating Middle East tensions revive inflation concerns. Brent crude has climbed t...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.